Allergan: FDA Approves BOTOX For Treating Neurogenic Detrusor Overactivity In Children

Allergan, an AbbVie (ABBV) company, announced the FDA has approved BOTOX for the treatment of detrusor (bladder muscle) overactivity associated with a neurologic condition in pediatric patients 5 …
( read original story …)


Advertisement